Yu Liu
Impact in
- Biological Psychiatry top 2%
- Oncology top 2%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 62
- Cancer Immunotherapy and Biomarkers 17
- Peptidase Inhibition and Analysis 15
- CAR-T cell therapy research 9
-
- Radiopharmaceutical Chemistry and Applications 14
- Medical Imaging Techniques and Applications 9
- Co-authors
- Stephen J. Riederer (3 shared papers)Phillip J. Rossman (2 shared papers)Richard L. Ehman (1 shared paper)Josef P. Debbins (1 shared paper)Qiang Zhang (1 shared paper)Jianqiang Lu (1 shared paper)Hui Sheng (1 shared paper)Weina Liu (1 shared paper)
- Journals
- Frontiers in Oncology (6 papers)PLoS ONE (5 papers)Frontiers in Immunology (5 papers)Scientific Reports (4 papers)Medicine (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yu Liu
244 papers receiving 4.4k citations
Yu Liu's Hit Papers
Peers
Comparison fields: 5 of 157
- Biological Psychiatry 135
- Oncology 864
- Radiology, Nuclear Medicine and Imaging 703
- Cancer Research 452
- Behavioral Neuroscience 91
Countries citing papers authored by Yu Liu
This map shows the geographic impact of Yu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Liu more than expected).
Fields of papers citing papers by Yu Liu
This network shows the impact of papers produced by Yu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Liu. The network helps show where Yu Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 263 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 224 | |
| 2 | 2015 | 179 | |
| 3 | 2006 | 166 | |
| 4 | 2017 | 154 | |
| 5 | 1993 | 133 | |
| 6 | 2008 | 131 | |
| 7 | 2013 | 125 | |
| 8 | Covalent targeted radioligands potentiate radionuclide therapy Hit paper breakdown → | 2024 | 114 |
| 9 | 2021 | 104 | |
| 10 | 2009 | 95 | |
| 11 | 2019 | 85 | |
| 12 | 2021 | 66 | |
| 13 | 2015 | 61 | |
| 14 | 2014 | 58 | |
| 15 | 1989 | 51 | |
| 16 | 2008 | 51 | |
| 17 | 2016 | 49 | |
| 18 | 2014 | 46 | |
| 19 | 2017 | 45 | |
| 20 | 2022 | 44 |
About Yu Liu
Yu Liu is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 263 papers that have together received 4.5k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (22 papers), Cancer Immunotherapy and Biomarkers (17 papers), Peptidase Inhibition and Analysis (15 papers), Radiopharmaceutical Chemistry and Applications (14 papers), Diabetes Treatment and Management (10 papers), RNA modifications and cancer (9 papers), Medical Imaging Techniques and Applications (9 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Biological Psychiatry (135 citations), Oncology (864 citations), Radiology, Nuclear Medicine and Imaging (703 citations), Cancer Research (452 citations) and Behavioral Neuroscience (91 citations). Yu Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Stephen J. Riederer, Phillip J. Rossman, Richard L. Ehman, Josef P. Debbins, Qiang Zhang, Jianqiang Lu, Hui Sheng, Weina Liu, Hua Zhang and Wan-Liang Lü. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, Frontiers in Immunology, Scientific Reports and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.